AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2021
Sep 10, 2021
29755_dirs_2021-09-10_5706e89a-6598-4314-b429-730f3ed8228a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-09-07
Reporting Person: Gosebruch Henry O (EVP, Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-07 | Common Stock, $0.01 par value | G | 30000 | — | Disposed | 18711 | Direct |
| 2021-09-07 | Common Stock, $0.01 par value | G | 30000 | — | Acquired | 78500 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $0.01 par value | 3289 | Indirect |
Footnotes
F1: The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2: Balance in AbbVie Savings program as of September 8, 2021.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4